Leveljump Healthcare Corp. (GOAL.P) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

Held by 0 DIIs

Promoter

27.15%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Sep 24

INTEREST(9M) At CAD 0.76 MM has Grown at 327.28%

With ROE of 31.36%, it has a attractive valuation with a 0.70 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Information Technology Services

Market cap

CAD 4 Million (Micro Cap)

P/E

2.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.55

Return on Equity

31.36%

Price to Book

0.57

Revenue and Profits:

Net Sales:

4 Million

(Quarterly Results - Sep 2024)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

30.0%

6 Months

30.0%

1 Year

30.0%

2 Years

-18.75%

3 Years

-13.33%

4 Years

-56.67%

5 Years

-59.38%

Leveljump Healthcare Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

31.68%

EBIT Growth (5y)

24.91%

EBIT to Interest (avg)

-1.16

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.64

Sales to Capital Employed (avg)

1.09

Tax Ratio

10.09%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

1.19%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.70

EV to EBIT

14.43

EV to EBITDA

7.48

EV to Capital Employed

0.88

EV to Sales

0.78

PEG Ratio

Dividend Yield

ROCE (Latest)

3.46%

ROE (Latest)

31.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2023

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 0.00% vs 7.32% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 100.00% vs 85.71% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.40",
          "val2": "4.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "0.50",
          "chgp": "40.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "52.60%",
          "val2": "20.60%",
          "chgp": "3.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 36.96% vs 37.31% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -1,200.00% vs 109.09% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.60",
          "val2": "9.20",
          "chgp": "36.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.50",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.10",
          "chgp": "300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.20",
          "val2": "0.20",
          "chgp": "-1,200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-65.40%",
          "val2": "-81.60%",
          "chgp": "1.62%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Sep'24

Jun'24

Change(%)

Net Sales

4.40

Operating Profit (PBDIT) excl Other Income

0.70

0.50

40.00%

Interest

0.30

Exceptional Items

0.00

Consolidate Net Profit

-0.00

-0.10

100.00%

Operating Profit Margin (Excl OI)

52.60%

20.60%

3.20%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2024 is 0.00% vs 7.32% in Jun 2024

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is 100.00% vs 85.71% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

12.60

9.20

36.96%

Operating Profit (PBDIT) excl Other Income

-0.20

-0.50

60.00%

Interest

0.40

0.10

300.00%

Exceptional Items

-0.10

0.00

Consolidate Net Profit

-2.20

0.20

-1,200.00%

Operating Profit Margin (Excl OI)

-65.40%

-81.60%

1.62%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 36.96% vs 37.31% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -1,200.00% vs 109.09% in Dec 2022

All Annual Results

Company CV

About Leveljump Healthcare Corp.

Leveljump Healthcare Corp.

Information Technology Services

No Details Available.

Company Coordinates

No Company Details Available